Fresenius | FRE - Equity Capital And Reserves


Fresenius reported EUR19.77B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Akzo Nobel EUR 4.88B 222M Mar/2026
Alcon AG USD 22.13B 99M Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 28.85B 2.9B Mar/2026
Beiersdorf EUR 8.6B 133M Dec/2025
DaVita Healthcare Partners USD -755.5M 104.41M Mar/2026
Demant DKK 9.84B 446M Dec/2025
E.ON EUR 28.83B 9.57B Mar/2026
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 19.77B 1.14B Dec/2025
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Getinge SEK 33.01B 2.75B Dec/2024
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
GN Store Nord DKK 10.12B 4.76B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Philips EUR 11.39B 403M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
RWE EUR 41.56B 3.9B Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
Smith & Nephew USD 5.54B 331M Dec/2025